Inotuzumab, CAS 1660159-36-3

Description: Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4 antibody targeting CD22. Inotuzumab is a naked antibody to Inotuzumab ozogamicin and can be used to synthesize antibody-active molecule conjugators (Inotuzumab ozogamicin). Inotuzumab can be used to study acute lymphoblastic leukemia and non-Hodgkin's lymphoma.

CAS Number: 1660159-36-3

References: Aujla A, et al. Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma. Biomark Res. 2019 Apr 11;7:9.

• Artikelnummer: TGMT76790-10mg
• Hersteller: TargetMol Chemicals
• Hersteller Artikelnummer: T76790-10mg
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK